Surevest’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$23K Sell
241
-15
-6% -$1.49K 0.01% 232
2022
Q2
$24K Buy
256
+15
+6% +$1.46K 0.01% 245
2022
Q1
$24K Hold
241
0.01% 226
2021
Q4
$25K Buy
+241
New +$22.3K 0.01% 222
2020
Q1
Sell
-6,656
Closed -$494K 102
2019
Q4
$494K Sell
6,656
-1,012
-13% -$71.1K 0.21% 107
2019
Q3
$484K Sell
7,668
-540
-7% -$32K 0.24% 105
2019
Q2
$447K Sell
8,208
-601
-7% -$32.4K 0.23% 106
2019
Q1
$475K Buy
8,809
+4,101
+87% +$253K 0.29% 95
2018
Q4
$308K Buy
+4,708
New +$351K 0.24% 81

Other funds holding CVS

Surevest's CVS Position: Q3 2022 in Review

Surevest reduced its CVS Health (CVS) stake by 5.9% in Q3 2022, selling an estimated $1.49K and leaving 241 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #232.

Surevest first reported a position in CVS in Q4 2018 and has held it in 9 quarters since. The position peaked at $494K in Q4 2019. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Surevest held 241 shares of CVS Health worth $23K as of Q3 2022.
  • Surevest sold 15 CVS Health shares in Q3 2022, an estimated $1.49K.
  • CVS Health made up 0.01% of Surevest's portfolio in Q3 2022, its #232 holding.
  • Surevest first reported a position in CVS Health in Q4 2018 and has held it in 9 quarters since.
  • Surevest's CVS Health position peaked at $494K in Q4 2019.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.